AI assistant
CVRx, Inc. — Director's Dealing 2021
Jun 30, 2021
33690_dirs_2021-06-29_94fd556f-ec51-4775-b2d9-f6de67712107.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CVRx, Inc. (CVRX)
CIK: 0001235912
Period of Report: 2021-06-29
Reporting Person: Yared Nadim (Director, Chief Executive Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7585 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $0.237 | 2025-08-06 | Common Stock (31037) | Direct | |
| Stock Option | $0.237 | 2025-08-06 | Common Stock (3792) | Direct | |
| Stock Option | $0.237 | 2025-08-06 | Common Stock (5916) | Direct | |
| Stock Option | $0.237 | 2025-08-06 | Common Stock (12641) | Direct | |
| Stock Option | $0.237 | 2025-08-06 | Common Stock (11377) | Direct | |
| Stock Option | $0.237 | 2023-11-11 | Common Stock (15745) | Direct | |
| Stock Option | $0.237 | 2024-09-10 | Common Stock (5057) | Direct | |
| Stock Option | $0.237 | 2025-06-30 | Common Stock (10114) | Direct | |
| Stock Option | $0.237 | 2025-06-30 | Common Stock (10114) | Direct | |
| Stock Option | $0.237 | 2026-09-27 | Common Stock (37093) | Direct | |
| Stock Option | $0.237 | 2028-02-15 | Common Stock (70041) | Direct | |
| Stock Option | $0.237 | 2028-02-15 | Common Stock (76615) | Direct | |
| Stock Option | $3.955 | 2029-07-23 | Common Stock (88499) | Direct | |
| Stock Option | $4.35 | 2030-09-30 | Common Stock (50900) | Direct | |
| Stock Option | $4.35 | 2030-09-30 | Common Stock (50184) | Direct | |
| Stock Option | $4.35 | 2030-09-30 | Common Stock (45635) | Direct | |
| Stock Option | $4.35 | 2030-09-30 | Common Stock (44859) | Direct | |
| Stock Option | $7.119 | 2031-02-03 | Common Stock (50570) | Direct |
Footnotes
F1: Fully exercisable.
F2: Fully exercisable, subject to Issuer's right to repurchase shares at exercise price, which repurchase right lapses with respect to 25% of the shares on the first anniversary of the date on which a certain revenue metric is achieved and with respect to the 1/48th of the shares on each month thereafter.
F3: Fully exercisable, subject to Issuer's right to repurchase shares at the exercise price, which repurchase right lapsed with respect to 25% of the shares on February 16, 2019 and lapses as to 1/48th of the shares each month thereafter.
F4: Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter.
F5: Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares on each month thereafter
F6: Vests as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares on each month thereafter.
F7: Vests as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares on each month thereafter.
F8: Vests as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares on each month thereafter.
F9: Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares on each month thereafter.